🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Akumentis Healthcare income crosses Rs 400 Cr in FY24; posts Rs 57 Cr profit

EntrackrEntrackr · 1y ago
Akumentis Healthcare income crosses Rs 400 Cr in FY24; posts Rs 57 Cr profit
Medial

Pharmaceutical company Akumentis Healthcare has reported a flat scale during the last fiscal year ending March 2024. However, the controlled cost mechanism helped the Thane-based firm to improve its margins and bottom line during the same period. Akumentis Healthcare saw a modest 2.8% increase in its scale to Rs 398 crore in FY24 from Rs 387 crore in FY23, its standalone financial statements filed with the Registrar of Companies show. *Note: Akumentis Healthcare is a wholly-owned subsidiary of Akum Drugs and Pharma Ltd which recorded a 14.3% increase in revenue to Rs 4,178 crore in FY24 from Rs 3,655 crore in FY23. Founded in 2010, Akumentis Healthcare provides medicinal products including creams and medicines across dermatology, orthopedics, gynecology, critical care, cardiovascular, diabetes, and pediatrics. The sale of these products was the sole source of revenue for the company. Akumentis made Rs 10 crore from interest and other miscellaneous sources tallying its overall income to Rs 409 crore in FY24. When it comes to burn, around 36.6% (Rs 122 crore) of its total burn went to employee benefits while cost of material consumed 31.5% (Rs 105 crore) of the overall expenditure in FY24. Its marketing (advertising cum promotion), commission paid to selling agents, traveling, legal and other overheads took Akumentis’ total expenditure to Rs 333 crore in FY24 from Rs 340 crore in FY23. Check TheKredible for more details. The controlled spending on employee benefits and related expenses helped Akumentis Healthcare increase its margins. As a result, the firm’s profit spiked 62.9% to Rs 57 crore in FY24 from Rs 35 crore in FY23. Its ROCE and EBITDA margin improved to 57.46% and 62.90%, respectively. On a unit level, Akumentis spent Rs 0.84 to earn a rupee. FY23-FY24 FY23 FY24 EBITDA Margin 19.26% 62.90% Expense/₹ of Op Revenue ₹0.88 ₹0.84 ROCE 65.38 57.46 Rajaram Samant, who was the co-founder and chief executive officer of Akumentis Healthcare for nearly 10 years, left the company in February 2020. Samant had previously worked at three large public companies: Ranbaxy, Emcure and Wanbury. In 2015, Peak XV had led a $19 million round in Akumentis.

Related News

Akumentis Healthcare posts Rs 66 Cr profit in FY25, revenue grows 9%

EntrackrEntrackr · 5m ago
Akumentis Healthcare posts Rs 66 Cr profit in FY25, revenue grows 9%
Medial

Akumentis Healthcare, a pharmaceutical company, reported a profit of Rs 66 crore in the fiscal year ending March 2025, marking a 16.8% increase compared to FY24. The company achieved this growth on the back of consistent revenue and controlled operating costs. Akumentis’ revenue from operations grew by 9% to Rs 433.5 crore in FY25 from Rs 398 crore in FY24, according to its financial statement sourced from the Registrar of Companies (RoC). Akumentis Healthcare operates on a branded formulations model, focusing on prescription-driven pharmaceuticals across therapeutic areas such as cardiology, dermatology, orthopedics, and gynecology. Sale of the products was the sole source of revenue. On the expense side, the cost of materials rose by 7.6% to Rs 113 crore in FY25 from Rs 105 crore in FY24. Employee benefit expenses increased by 8% to Rs 132 crore, while advertising expenses remained flat at Rs 39 crore. Travelling expenses rose 7% to Rs 30 crore, whereas legal and professional fees surged 25% to Rs 20 crore during the year. Overall, Akumentis’ total expenses grew nearly 9% to Rs 361.5 crore in FY25 from Rs 333 crore in FY24. The combination of steady top-line growth and measured spending helped the company expand profitability. Akumentis’ profit rose by 17% to Rs 66 crore in FY25 from Rs 56.5 crore in FY24. Its ROCE and EBITDA margin stood at 43.70% and 19.91% respectively. On a unit level, the company spent Rs 0.83 to earn a rupee during FY25. The company recorded current assets worth Rs 167 crore in FY25, including Rs 92 crore in cash and bank balances. According to TheKredible, Akumentis has raised a total of $19 million of funding till date, with Peak XV Partners as its lead investor.

Awfis income crosses Rs 300 Cr in Q2 FY25, posts Rs 38 Cr PAT

EntrackrEntrackr · 1y ago
Awfis income crosses Rs 300 Cr in Q2 FY25, posts Rs 38 Cr PAT
Medial

Co-working solutions provider Awfis has registered decent growth in its revenue while maintaining profitability in the second quarter of FY25. The company’s revenue from operations surged 40.5% year-on-year to Rs 292.38 crore in Q2 FY25 from Rs 208.15 crore in the same quarter last year. Other income contributed an additional Rs 9.56 crore which drove its total income of Rs 301.95 crore for the quarter. On a quarterly basis, the firm's revenue jumped 13.46% from Rs 258 crore in Q1 FY25. Founded in 2015, Awfis provides office spaces for startups, SMEs, and large corporations, along with services such as food and beverages, IT support, and infrastructure solutions. Revenue from co-working spaces remained the largest segment that grew 43.1% to Rs 218.31 crore in Q2 FY25 from Rs 152.56 crore in Q2 FY24. The construction and fit-out projects segment brought in Rs 68.15 crore, while other services brought in Rs 5.9 crore to the overall revenue in Q2 FY25. Subcontracting cost was the largest burn which stood at Rs 56.13 crore, whereas employee benefits expenses increased to Rs 39.38 crore. Depreciation and amortization expenses grew 33.5% YoY to Rs 64 crore. Finance costs amounted to Rs 30.4 crore which pushed the firm’s total cost to Rs 287.29 crore in the September quarter. With an exceptional item income of Rs 24 crore, Awfis posted a profit after tax of Rs 38.67 crore. Awfis’ stock was listed on the NSE on May 30, opening at Rs 435 with a 13.58% premium over the issue price of Rs 383. Before Monday’s market closure, the company’s shares were trading at Rs 776.

Nykaa posts Rs 2,061 Cr revenue in Q4 FY25, profit soars 90%

EntrackrEntrackr · 9m ago
Nykaa posts Rs 2,061 Cr revenue in Q4 FY25, profit soars 90%
Medial

Online beauty and fashion platform Nykaa reported strong growth in Q4 FY25, with its revenue from operations rising 24% year-on-year and profits surging 90% during the quarter ending March 2025. According to its consolidated financial statements sourced from the NSE, Nykaa's revenue from operations grew to Rs 2,061 crore in Q4 FY25, compared to Rs 1,667 crore in Q4 FY24. For the full fiscal year (FY25), Nykaa’s operating revenue increased 24% to Rs 7,950 crore in FY25 from Rs 6,386 crore in FY24. The beauty segment accounted for 92% of the total revenue at Rs 1,894 crore, while the fashion segment contributed 8% of the operating income in the last quarter. For Nykaa, the cost of materials constituted 57% of its total expenditure, rising to Rs 1,153 crore in Q4 FY25. Additional spending on employee benefits, finance, marketing, technology, and other overheads brought the company’s total costs to Rs 2,031 crore during the quarter. For the full fiscal year ending March 2025, the total expenses rose to Rs 7,850 crore. Steady growth in its scale helped Nykaa achieve a 90% increase in profit to Rs 19 crore in Q4 FY25, compared to Rs 10 crore in Q4 FY24. For FY25, the firm’s profit stood at Rs 74 crore in FY25 from Rs 44 crore in FY24. At the close of today's trading session, Nykaa's stock was priced at Rs 200.8, giving the company a market capitalization of Rs 57,406 crore.

CarTrade posts Rs 169 Cr revenue in Q4 FY25, profit jumps 2X

EntrackrEntrackr · 9m ago
CarTrade posts Rs 169 Cr revenue in Q4 FY25, profit jumps 2X
Medial

CarTrade has released its financial results for the fourth quarter of the last fiscal year (Q4 FY25) on Wednesday. The company reported a 17% year-on-year revenue growth compared to Q4 FY24, with profit doubling in the same time period. CarTrade’s revenue from operations grew 17% to Rs 169 crore in Q4 FY25 in contrast to Rs 145 crore in Q4 FY24, as per the firm’s unaudited consolidated financial results sourced from the National Stock Exchange. For the full fiscal year ending March 2025, CarTrade’s revenue rose 31% to Rs 641 crore. Including other undisclosed income, its total income for Q4 FY25 grew to Rs 189 crore, up from Rs 161 crore in Q4 FY24. The Mumbai-based company operates in three segments: Consumer, Remarketing, and Classifieds. Income from the consumer segment formed 37% of the total operating revenue which increased to Rs 63 crore in Q4 FY25 from Rs 49 crore in Q4 FY24. Income from the remarketing and classified segment stood at Rs 59 crore and Rs 47 crore, respectively, in the fourth quarter of the ongoing fiscal year. During the full fiscal year (FY25), income from the consumer segment stood at Rs 238 crore, whereas collection from the remarketing and classified segment stood at Rs 212 crore and Rs 192 crore, respectively. On the expense front, employee benefits expenses formed 52% of the overall spending which went up a modest 6% to Rs 71 crore during the period. Including other costs, CarTrade’s overall expenses increased 4% to Rs 136 crore in Q4 FY25 from Rs 131 crore during Q4 FY24. On a fiscal-on-fiscal year basis, its overall expenses increased to Rs 543 crore in the last fiscal year from Rs 457 crore in FY24. The decent growth and controlled spending enabled CarTrade to double its net profit to Rs 46 crore in Q4 FY25, compared to Rs 23 crore in Q4 FY24. On a fiscal basis, the company’s profit spiked to Rs 145 crore in FY25. CarTrade recorded a 5.8% hike in its share price today and is trading at Rs 1,721 (as of 12:50) with a total market capitalization of Rs 8,168 crore.

Fibe crosses Rs 1,200 Cr revenue in FY25; profit spikes 13%

EntrackrEntrackr · 10d ago
Fibe crosses Rs 1,200 Cr revenue in FY25; profit spikes 13%
Medial

Fibe crosses Rs 1,200 Cr revenue in FY25; profit spikes 13% In the fiscal year ending March 2025, the consumer lending firm Fibe reported nearly 50% growth in operating revenue to over Rs 1,200 crore, while profit also rose in double digits. Fibe, formerly EarlySalary, recently raised $35 million in a Series F round led by the International Finance Corporation. The impact of this funding will likely reflect in FY26. In the fiscal year ending March 2025, the consumer lending firm reported nearly 50% growth in operating revenue to over Rs 1,200 crore, while profit also rose in double digits. Fibe’s revenue from operations grew 49% year-on-year to Rs 1,228 crore in FY25 from Rs 824 crore in FY24, according to its consolidated financial statements filed with the Registrar of Companies (RoC). Co-founded in 2015 by Akshay Mehrotra and Ashish Goyal, Fibe provides personal loans, long-term loans, loans against mutual funds, and fixed deposits across healthcare, education, and solar rooftop installations. It claims to have facilitated more than 9 million loans, with total disbursements exceeding Rs 40,000 crore through over 8,500 lenders. Interest on loans was the largest revenue contributor for Fibe, with over 80% share of its total operating revenue. This income rose 46% in FY25 and crossed the Rs 1,000 crore mark. The company also earned servicing fee income for managing loan collections and administration on behalf of lending partners. It has partnered with several banks and NBFCs, including Northern Arc Capital, InCred Finance, Tata Capital, and many others. Income from guarantee premium, i.e., fees earned for providing default protection to lending partners, also stood at Rs 104 crore for Fibe and grew 83% year-on-year. The remaining revenue came from marketing income, commission income, and other operating sources. Fibe also earned around Rs 41 crore from non-operating sources such as interest income and gains on the sale of current investments, and this took its total income to Rs 1,269 crore in the last fiscal year. For the consumer lending company, finance cost formed the largest cost centre, with over 62% share of the total expenditure, and stood at Rs 691 crore in FY25 for Fibe. This cost rose 85% year-on-year from Rs 373 crore in FY24. Notably, it included Rs 257 crore towards loan write-offs and Rs 207 crore as loss on guarantees invoked. Advertising and promotional expenses, another major cost centre for Fibe, stood at Rs 128 crore in FY25. Employee benefit expenses, which accounted for under 10% of the total cost, rose 34% to Rs 111 crore, including Rs 9.2 crore of ESOP expenses. Commission paid to selling agents, legal & professional, travelling and other miscellaneous overheads took the overall expenses for the firm to Rs 1,112 crore in FY25 from Rs 706 crore in FY24. Higher non-operating income, which rose from Rs 18 crore to Rs 41 crore, helped the Pune-based firm post a 13% increase in profit to Rs 114 crore. Fibe spent Rs 0.91 to earn one rupee of operating revenue on a unit basis. As of March 2025, it had total current assets of Rs 3,135 crore, which includes cash and bank balance of Rs 259 crore. Fibe has raised over $265 million to date, including a $90 million Series E round led by TR Capital, Trifecta Capital, and Amara Partners. In August last year, Fibe also raised Rs 250 crore in debt for its lending arm, EarlySalary, from a group of investors including AK Capital Finance.

Garuda Aerospace posts Rs 17.5 Cr profit in FY25, revenue at Rs 118 Cr

EntrackrEntrackr · 6m ago
Garuda Aerospace posts Rs 17.5 Cr profit in FY25, revenue at Rs 118 Cr
Medial

Garuda Aerospace posts Rs 17.5 Cr profit in FY25, revenue at Rs 118 Cr Drone technology startup Garuda Aerospace reported a modest growth in the last financial year ending March 31, 2025. The Bengaluru-based firm maintained profitability, supported by steady revenue growth and cost discipline. Garuda’s revenue from operations increased 7.3% to Rs 118 crore in FY25 from Rs 110 crore in FY24, as per its unaudited financial statements filed with the Registrar of Companies (RoC). Garuda Aerospace designs, manufactures and customizes Unmanned Aerial Vehicle (UAVs or drones) for various use cases such as deliveries, disaster management and agriculture. The company made additional Rs 7 crore from other income, which increased its total income to Rs 125 crore in FY25, from Rs 111 crore in FY24. Looking at the expenses, the cost of materials, which formed the largest expense, rose 14% to Rs 56 crore in FY25 from Rs 49 crore a year ago. Employee benefit expenses declined 12% to Rs 9.23 crore, while finance costs halved to Rs 1 crore during the same period. Depreciation, however, increased to Rs 3 crore in FY25 from Rs 2 crore in FY24. Overall, Garuda’s total expenses grew 13% to Rs 100.5 crore in FY25 as against Rs 89 crore in FY24. Despite higher spending, the company managed to expand its bottom line, with profit after tax (PAT) rising 9.4% to Rs 17.5 crore in FY25, from Rs 16 crore in FY24. Its ROCE and EBITDA margin stood at 14.37% and 22.4% respectively. On a unit level, Garuda spent Rs 0.85 to earn a rupee of revenue during the fiscal year. The company recorded current assets worth Rs 179 crore. According to startup data intelligence platform TheKredible, Garuda Aerospace has raised approximately $44 million to date from investors such as Nagarajan Seyyadurai, Ocgrow Ventures, cricketer MS Dhoni and others. Garuda operates a fleet of 400 drones and 500 pilots across 84 cities. The company recently raised funds from Narotam Sekhsaria Family Office to scale up manufacturing capacity from the current 8,000 drones annually to between 12,000 and 15,000 units. It will also expand its export presence to 50 countries by the year-end.

Drishti IAS posts Rs 405 Cr revenue and Rs 90 Cr PAT in FY24

EntrackrEntrackr · 1y ago
Drishti IAS posts Rs 405 Cr revenue and Rs 90 Cr PAT in FY24
Medial

Drishti IAS posts Rs 405 Cr revenue and Rs 90 Cr PAT in FY24 Offline coaching firm Drishti IAS Institute crossed Rs 400 crore of revenue during the previous fiscal year ended in March 2024. The profits for the Vikas Divyakirti-led firm touched Rs 90 crore in the same period. Drishti IAS’s revenue from operations increased by 30.6% year-on-year to Rs 405 crore in FY24 from Rs 310 crore in FY23. The Delhi-based company's revenue rose from Rs 40 crore in FY21 to Rs 119 crore in FY22, and further to Rs 310 crore in FY23. The 26-year-old educational platform mainly provides offline coaching for Civil Services Examination (CSE). Income from coaching services accounted for 94.8% of the total operating revenue, which increased by 37.6% to Rs 384 crore in FY24 from Rs 279 crore in FY23. The remaining income is generated from the sale of study materials, including pen drives, books, test papers, and other resources. Drishti IAS operates seven institutes, including two in Delhi, three in Uttar Pradesh, and one each in Jaipur and Indore. Its Mukherjee Nagar Institute is the largest revenue contributor, accounting for 58% of the total coaching income. Employee benefits and faculty charges constituted 40% of its overall cost, increasing by 41% to Rs 117 crore in FY24 from Rs 83 crore in FY23. Drishti IAS's advertising spending also jumped 3.4X to Rs 51 crore in FY24. Drishti IAS's overall expenditure increased to Rs 289 crore in FY24 from Rs 197 crore in FY23. Higher spending on employee benefits and advertising resulted in a modest 3.4% increase in net profits, which rose to Rs 90 crore in FY24 from Rs 87 crore in FY23. The company's ROCE and EBITDA margin were recorded at 55.7% and 33.73%, respectively, while the expense-to-revenue ratio stood at Re 0.71. As of March 2024, the company's total current assets were valued at Rs 88 crore, with cash and bank balances of Rs 54 crore.

Upstox posts Rs 1,208 Cr income and Rs 215 Cr profit in FY25

EntrackrEntrackr · 1m ago
Upstox posts Rs 1,208 Cr income and Rs 215 Cr profit in FY25
Medial

Upstox posts Rs 1,208 Cr income and Rs 215 Cr profit in FY25 Stockbroking firm Upstox reported flat revenue in the fiscal year ended March 2025, but improved profitability by 21.5% to Rs 215 crore, driven largely by higher non-operating income. Upstox’s revenue from operations remained flat at Rs 945 crore in the fiscal year ended March 2025, compared to Rs 951 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Upstox provides retail investors with investment options, including stocks, IPOs, futures & options (F&O), commodities, currencies, fixed deposits, peer-to-peer lending, government bonds, non-convertible debentures (NCDs), gold, and insurance. As of December 2025, Upstox has 2.08 million active clients with a market share of 4.64%. Brokerage income remained the company’s primary revenue stream at Rs 767 crore, which formed over 81% of total income. Depository operations added Rs 65 crore, while the remaining Rs 113 crore came from management services and other operating income. The company also reported Rs 263 crore in non-operating income, for which no detailed breakup was provided. Including this, the company’s total income for FY25 stood at Rs 1,205 crore. On the cost front, advertising and business promotion expenses remained the largest cost head for the stockbroking firm, accounting for over 47% of total expenses at Rs 467 crore. This spend was largely flat compared to Rs 455 crore in FY24. Upstox’s employee benefit expenses rose 11% year-on-year to Rs 211 crore, including Rs 13.6 crore in non-cash ESOP costs, while legal and professional expenses declined 8% to Rs 123 crore. Other overheads, including finance costs, depreciation and amortisation, travel, and miscellaneous expenses, pushed the company’s total expenses to Rs 991 crore in the last fiscal year, which grew 6% from Rs 935 crore in FY24. Overall, while Upstox’s revenue and expenses remained largely flat in FY25, a Rs 103 crore increase in non-operating income helped the company post a 21.5% rise in profit to Rs 215 crore, compared to Rs 177 crore in FY24. The company’s ROCE and EBITDA margin stood at -0.45% and 0.98% respectively in FY25, with a positive EBITDA of Rs 9 crore. As of March 2025, its current assets totaled Rs 4,029 crore, including a healthy cash and bank balance of Rs 2,744 crore. Upstox has raised over $200 million to date and was last valued at $3.5 billion. Data from startup intelligence platform TheKredible shows Tiger Global as the largest external shareholder with a 38.54% stake. Upstox competes with players such as Zerodha, Groww, and Angel One. In FY25, Zerodha reported revenue of Rs 8,847 crore with a profit of Rs 4,237 crore, while Groww posted a 50% year-on-year rise in revenue to Rs 3,902 crore. Angel One reported revenue of Rs 5,238 crore during the year.

Treebo crosses Rs 100 Cr revenue in FY24, outstanding losses climb to Rs 488 Cr

EntrackrEntrackr · 1y ago
Treebo crosses Rs 100 Cr revenue in FY24, outstanding losses climb to Rs 488 Cr
Medial

Treebo crosses Rs 100 Cr revenue in FY24, outstanding losses climb to Rs 488 Cr Treebo Hotels, a premium-budget hotel chain, crossed the Rs 100 crore revenue milestone in the fiscal year ending March 2024. Despite this growth, the Bengaluru-based company saw its losses rise by 17%, bringing total outstanding losses to Rs 488 crore. Treebo Hotels’s revenue from operations grew 22.5% to Rs 109 crore in FY24 from Rs 89 crore in FY23, its consolidated financial statements filed with the Registrar of Companies show. Income from accommodation services (taken on lease and managed properties) formed 95% of the total operating revenue which increased by 22.3% to Rs 104 crore in FY24 from Rs 85 crore in FY23. The rest of the income comes from the sale of products, and subscription services. The company also added Rs 7.22 crore as other income (non-operating) which tallied its overall revenue to Rs 116 crore in FY24 from Rs 94 crore in FY23. Treebo spent 41% of its overall expenditure on employee benefits which increased marginally by 7% to Rs 59 crore in FY24. Its cost and commission surged 70% and 48% to Rs 17 crore and Rs 43 crore in the previous fiscal year. Its cost of materials, legal, technology, traveling, and other overheads took the overall cost up by 22% to Rs 144 crore in FY24 from Rs 118 crore in FY23. The increased advertising and commission costs led Treebo to raise its losses by 16.7% to Rs 28 crore in FY24, compared to Rs 24 crore in FY23. Its ROCE and EBITDA margin stood at -540% and -18.1% respectively. On a unit level, it spent Rs 1.32 to earn a rupee in FY24. The company’s total current assets stood at Rs 34 crore with cash and bank balances of Rs 7 crore in the previous fiscal. According to startup data intelligence platform TheKredible, decade-old Treebo has secured Rs 566 crore (approximately $70 million) in funding from investors including Accor, Elevation Capital, Matrix Partners, and Bertelsmann. The company’s most recent major funding, amounting to $16 million, was raised in June 2021. Treebo competes directly with Bloom Hotels and FabHotels. In FY24, Bloom Hotels saw its operational revenue rise by 73.6% to Rs 250 crore, with a profit of Rs 14 crore. FabHotels recorded Rs 224 crore in operating revenue for FY23 but has not yet filed its FY24 annual report.

NephroPlus posts Rs 566 Cr revenue and Rs 35 Cr profit in FY24

EntrackrEntrackr · 10m ago
NephroPlus posts Rs 566 Cr revenue and Rs 35 Cr profit in FY24
Medial

NephroPlus posts Rs 566 Cr revenue and Rs 35 Cr profit in FY24 Dialysis service provider NephroPlus reported a 29% year-on-year increase in operating revenue for the fiscal year ending March 2024. Significantly, the Hyderabad-based company turned profitable during the period, marking a notable recovery from a Rs 12 crore loss in FY23. NephroPlus’ operating revenue grew to Rs 566 crore in FY24 from Rs 438 crore in FY23, according to its consolidated financial statement sourced from the Registrar of Companies (RoC). NephroPlus runs over 275 dialysis centers in more than 170 cities in India and treats nearly 20,000 patients on a monthly basis. Revenue from these services accounted for 95% of the company’s income in FY24. On the expense side, the largest component of expenditure remained the cost of materials, which rose 19% to Rs 169 crore, accounting for over 31% of the total spend. Employee benefit expenses dropped slightly to Rs 91 crore from Rs 97 crore in FY23, while healthcare professional fees surged by 90% to Rs 59 crore. Hospital fees also increased to Rs 56 crore from Rs 48 crore, and other operational expenses climbed to Rs 166 crore. Overall, NephroPlus reported total costs rose 19.7% to Rs 541 crore in FY24. The strategic focus on cost discipline and improved margins helped NephroPlus post a net profit of Rs 35 crore in FY24, as compared to a net loss of Rs 12 crore a year earlier. Its ROCE and EBITDA margin improved to 9.40% and 18.96% respectively. On a unit basis, NephroPlus spent Rs 0.96 to earn a rupee of revenue in FY24. As of March 2024, the company reported current assets worth Rs 390 crore in FY24, out of which Rs 61 crore were in cash and bank balances. According to startup data intelligence platform TheKredible, NephroPlus has raised approximately $212 million in funding to date, having IFC and Besemer Venture Partners as its lead investors. The company’s co-founder and CEO Vikram Vuppala owns 11.6% of the company. Recently, NephroPlus acquired seven new dialysis clinics in the Philippines. The firm is also planning to start its clinics in Saudi Arabia later this year.

Download the medial app to read full posts, comements and news.